Merit Medical Systems (MMSI) Tops Q2 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Merit Medical Systems (MMSI) Announces Proposed 3.5M Share Common Offering
July 24, 2018 4:14 PM EDTMerit Medical Systems, Inc. (NASDAQ: MMSI) today announced that it has commenced an underwritten public offering of shares of its common stock. Merit expects to offer 3,500,000 shares of common stock and also plans to grant the underwriters participating in the offering a 30-day... More
Merit Medical Systems, Inc. (MMSI) PT Raised to $61 at Barrington Research
July 24, 2018 8:30 AM EDTBarrington Research raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $61.00 (from $50.00) while maintaining a Outperform rating.
... MoreMerit Medical Systems, Inc. (MMSI) PT Raised to $70 at Canaccord Genuity
July 24, 2018 7:08 AM EDTCanaccord Genuity raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $70.00 (from $60.00) while maintaining a Buy rating.
... MoreMerit Medical Systems, Inc. (MMSI) PT Raised to $67 at Needham & Company
July 24, 2018 6:31 AM EDTNeedham & Company raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $67.00 (from $54.00) while maintaining a Buy rating.
Analsyt Mike Matson commented, "MMSI's 2Q18 revenue and EPS beat consensus. Management raised its 2018 revenue and EPS guidance but lowered its 2018 gross margin... More



